Abstract
The host genetic background, complex surrounding environments, and gut microbiome are very closely linked to human and animal health and disease. Although significant correlations between gut microbiota and human and animal health have been revealed, the specific roles of each gut bacterium in sha** human and animal health and disease remain unclear. However, recent omics-based studies using experimental animals and surveys of gut microbiota from unhealthy humans have provided insights into the relationships among microbial community, their metabolites, and human and animal health. This editorial introduces six review papers that provide new discoveries of disease-associated microbiomes and suggest possible microbiome-based therapeutic approaches to human disease.
Article PDF
Avoid common mistakes on your manuscript.
References
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., de-Roos, P., Liu, H., Cross, J.R., Pfeffer, K., Coffer, P.J., et al. 2013. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504, 451–455.
Aron-Wisnewsky, J. and Clement, K. 2016. The gut microbiome, diet, and links to cardiometabolic and chronic disorders. Nat. Rev. Nephrol. 12, 169–181.
Bravo, J.A., Forsythe, P., Chew, M.V., Escaravage, E., Savignac, H.M., Dinan, T.G., Bienenstock, J., and Cryan, J.F. 2011. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc. Natl. Acad. Sci. USA 108, 16050–16055.
Bravo, J.A., Julio-Pieper, M., Forsythe, P., Kunze, W., Dinan, T.G., Bienenstock, J., and Cryan, J.F. 2012. Communication between gastrointestinal bacteria and the nervous system. Curr. Opin. Pharmacol. 12, 667–672.
Cho, J.A. and Chinnapen. D.J.F. 2018. Targeting friend and foe: Emerging therapeutics in the age of gut microbiome and disease. J. Microbiol. 56, 183–188.
Ding, S., Chi, M.M., Scull, B.P., Rigby, R., Schwerbrock, N.M., Magness, S., Jobin, C., and Lund, P.K. 2010. High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS One 5, e12191.
Eom, T., Kim, Y.S., Choi, C.H., Sadowsky, M.J., and Unno, T. 2018. Current understanding of microbiota-and dietary-therapies for treating inflammatory bowel disease. J. Microbiol. 56, 189–198.
Grenham, S., Clarke, G., Cryan, J.F., and Dinan, T.G. 2011. Brain-gut microbe communication in health and disease. Front. Physiol. 2, 94.
Harach, T., Marungruang, N., Duthilleul, N., Cheatham, V., McCoy, K.D., Frisoni, G., Neher, J.J., Fak, F., Jucker, M., Lasser, T., et al. 2017. Reduction of Aβ amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota. Sci. Rep. 7, 41802.
Kim, N., Yun, M., Oh, Y.J., and Choi, H.J. 2018. Mind-altering with the gut: Modulation of the gut-brain axis with probiotics. J. Microbiol. 56, 172–182.
Klose, C.S.N. and Artis, D. 2016. Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis. Nat. Immunol. 17, 765–774.
La Reau, A.J., Meier-Kolthoff, J.P., and Suen, G. 2016. Sequencebased analysis of the genus Ruminococcus resolves its phylogeny and reveals strong host association. Microb. Genomics 2, e000099.
La Reau, A.J. and Suen, G. 2018. The Ruminococci: key symbionts of the gut ecosystem. J. Microbiol. 56, 199–208.
Ley, R.E., Turnbaugh, P.J., Klein, S., and Gordon, J.I. 2006. Microbial ecology: Human gut microbes associated with obesity. Nature 444, 1022–1023.
Lopez, C.A., Kingsbury, D.D., Velazquez, E.M., and Baumler, A.J. 2014. Collateral damage: microbiota-derived metabolites and immune function in the antibiotic era. Cell Host Microbe 16, 156–163.
Ng, K.M., Ferreyra, J.A., Higginbottom, S.K., Lynch, J.B., Kashyap, P.C., Gopinath, S., Naidu, N., Choudhury, B., Weimer, B.C., Monack, D.M., et al. 2013. Microbiota liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 502, 96–99.
Park, J. and Eberl, G. 2018. Type 3 regulatory T cells at the interface of symbiosis. J. Microbiol. 56, 163–171.
Sittipo, P., Lobionda, S., Lee, Y.K., and Maynard, C.L. 2018. Intestinal microbiota and the immune system in metabolic diseases. J. Microbiol. 56, 154–162.
Tang, W.H., Kitai, T., and Hazen, S.L. 2017. Gut microbiota in cardiovascular health and disease. Circ. Res. 120, 1183–1196.
Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R., Gordon, J.I. 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027–1031.
van de Pavert, S.A., Ferreira, M., Domingues, R.G., Ribeiro, H., Molenaar, R., Moreira-Santos, L., Almeida, F.F., Ibiza, S., Barbosa, I., Goverse, G., et al. 2014. Maternal retinoids control type 3 innate lymphoid cells and set the offspring immunity. Nature 508, 123–127.
Wegmann, U., Louis, P., Goesmann, A., Henrissat, B., Duncan, S.H., and Flint, H.J. 2013. Complete genome of a new Firmicutes species belonging to the dominant human colonic microbiota (‘Ruminococcus bicirculans’) reveals two chromosomes and a selective capacity to utilize plant glucans. Environ. Microbiol. 16, 2879–2890.
Yamashiro, K., Tanaka, R., Urabe, T., Ueno, Y., Yamashiro, Y., Nomoto, K., Takahashi, T., Tsuji, H., Asahara, T., and Hattori, N. 2017. Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke. PLoS One 12, e0171521.